This article offers promising treatment improvements for many women that suffer from PPD. It is such an underdiagnosed condition. I look forward to future information on treatment for this population.
GENERATION NPThis article offers promising treatment improvements for many women that suffer from PPD. It is such an underdiagnosed condition. I look forward to future information on treatment for this population.
This article offers promising treatment improvements for many women that suffer from PPD. It is such an underdiagnosed condition. I look forward to future information on treatment for this population.
Using measures beyond weight and BMI are important such as weight circumference, fat percentage, cardiac risk markers, insulin resistance and related comorbidities. Making it a regular part of a discussion of health risks and removing any and all terminology that assigns blame or fault to the individual.
Cardiovascular Risk Reduction is the number one reason to properly manage dyslipidemia. Primary care providers play a key role in identifying and managing dyslipidemia to reduce the risk of these serious health events. By controlling lipid levels, providers can help prevent the progression of atherosclerosis, which can reduce morbidity and mortality associated with cardiovascular conditions. Primary care providers are in a unique position to educate patients about lifestyle modifications (such as diet, exercise, and smoking cessation) that can positively impact lipid levels. Empowering patients through education can enhance adherence to treatment plans and promote healthier behaviors. Most national and international health guidelines recommend routine screening and management of dyslipidemia in adults, which underscores its importance in primary care. Primary care providers are essential for ensuring adherence to these guidelines. In summary, managing dyslipidemia is important for primary care providers because it is a fundamental aspect of preventing cardiovascular disease, improving patient outcomes, promoting overall health, and adhering to best practices in preventive care.
I regularly use combo bronchodilators for patients with COPD and persistent dyspnea. They are particularly effective for patients without a history of exacerbations. I do regularly evaluate lab work to rule out TH2-mediated inflammation. If there is evidence of this I tend to add in an ICS inhaler. I think consistency is key for these patients. If they derive benefit and understand the nature of chronic lung disease they tend to be compliant.
This may be more beneficial for patients with uncontrolled diabetes along with weight problems. Either with other medications, the combination therapy has been known to have a stronger response and also manages their appetite to lose weight and in itself can also reduce carb intake and reduce hga1c.
Approximately 75-80% of my patients wish to lose weight. The resources that my patients have found to help aid them is using apps for Tracking Food and Activity, such as My Fitness Pal app, as well as using exercise apps. Patients are requesting Saxenda, Wegovy, [Ozempic and Mounjaro-off label use] to help speed up the weight loss process, but education is key to help with maintaining the weight loss and implementing lifestyle changes to sustain their weight loss.